Loading clinical trials...
Loading clinical trials...
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration (SERENE)
This study is a pragmatic, randomized controlled pilot trial comparing remimazolam with propofol for endoscopic procedures, designed to assess the feasibility and clinical outcomes associated with implementing a pragmatic randomized trial of sedation practices in the endoscopy setting.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
March 3, 2026
Primary Completion Date
June 1, 2026
Completion Date
June 1, 2026
Last Updated
March 5, 2026
100
ESTIMATED participants
Remimazolam
DRUG
Propofol
DRUG
Lead Sponsor
Massachusetts General Hospital
NCT06346132
NCT06430957
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions